The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mucopolysaccharidosis II-Global Market Insights and Sales Trends 2025
Synopsis
The global Mucopolysaccharidosis II market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mucopolysaccharidosis II in various end use industries. The expanding demands from the Hospital, Clinic, Research Center and Others, are propelling Mucopolysaccharidosis II market. JR-141, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the EGT-301 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Mucopolysaccharidosis II market, driven by demand from China, the second largest economy with some signs of stabilising, the Mucopolysaccharidosis II market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mucopolysaccharidosis II, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mucopolysaccharidosis II market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mucopolysaccharidosis II market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mucopolysaccharidosis II sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mucopolysaccharidosis II covered in this report include Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, Inventiva, JCR Pharmaceuticals Co., Ltd., Laboratorios Del Dr. Esteve S.A. and RegenxBio Inc., etc.
The global Mucopolysaccharidosis II market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alexion Pharmaceuticals, Inc.
AngioChem Inc.
ArmaGen Inc.
Bioasis Technologies Inc.
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co., Ltd.
Laboratorios Del Dr. Esteve S.A.
RegenxBio Inc.
Sangamo BioSciences, Inc.
Takeda
Global Mucopolysaccharidosis II market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mucopolysaccharidosis II market, Segment by Type:
JR-141
EGT-301
DUOC-01
AGT-182
JR-032
Others
Global Mucopolysaccharidosis II market, by Application
Hospital
Clinic
Research Center
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mucopolysaccharidosis II manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mucopolysaccharidosis II in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Mucopolysaccharidosis II market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mucopolysaccharidosis II in various end use industries. The expanding demands from the Hospital, Clinic, Research Center and Others, are propelling Mucopolysaccharidosis II market. JR-141, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the EGT-301 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Mucopolysaccharidosis II market, driven by demand from China, the second largest economy with some signs of stabilising, the Mucopolysaccharidosis II market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mucopolysaccharidosis II, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mucopolysaccharidosis II market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mucopolysaccharidosis II market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mucopolysaccharidosis II sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mucopolysaccharidosis II covered in this report include Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, Inventiva, JCR Pharmaceuticals Co., Ltd., Laboratorios Del Dr. Esteve S.A. and RegenxBio Inc., etc.
The global Mucopolysaccharidosis II market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alexion Pharmaceuticals, Inc.
AngioChem Inc.
ArmaGen Inc.
Bioasis Technologies Inc.
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co., Ltd.
Laboratorios Del Dr. Esteve S.A.
RegenxBio Inc.
Sangamo BioSciences, Inc.
Takeda
Global Mucopolysaccharidosis II market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mucopolysaccharidosis II market, Segment by Type:
JR-141
EGT-301
DUOC-01
AGT-182
JR-032
Others
Global Mucopolysaccharidosis II market, by Application
Hospital
Clinic
Research Center
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mucopolysaccharidosis II manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mucopolysaccharidosis II in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Mucopolysaccharidosis II Market Overview
1.1 Mucopolysaccharidosis II Product Overview
1.2 Mucopolysaccharidosis II Market Segment by Type
1.2.1 JR-141
1.2.2 EGT-301
1.2.3 DUOC-01
1.2.4 AGT-182
1.2.5 JR-032
1.2.6 Others
1.3 Global Mucopolysaccharidosis II Market Size by Type
1.3.1 Global Mucopolysaccharidosis II Market Size Overview by Type (2018-2029)
1.3.2 Global Mucopolysaccharidosis II Historic Market Size Review by Type (2018-2023)
1.3.3 Global Mucopolysaccharidosis II Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Mucopolysaccharidosis II Sales Breakdown by Type (2018-2023)
1.4.2 Europe Mucopolysaccharidosis II Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Mucopolysaccharidosis II Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Mucopolysaccharidosis II Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Mucopolysaccharidosis II Sales Breakdown by Type (2018-2023)
2 Global Mucopolysaccharidosis II Market Competition by Company
2.1 Global Top Players by Mucopolysaccharidosis II Sales (2018-2023)
2.2 Global Top Players by Mucopolysaccharidosis II Revenue (2018-2023)
2.3 Global Top Players by Mucopolysaccharidosis II Price (2018-2023)
2.4 Global Top Manufacturers Mucopolysaccharidosis II Manufacturing Base Distribution, Sales Area, Product Type
2.5 Mucopolysaccharidosis II Market Competitive Situation and Trends
2.5.1 Mucopolysaccharidosis II Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Mucopolysaccharidosis II Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mucopolysaccharidosis II as of 2022)
2.7 Date of Key Manufacturers Enter into Mucopolysaccharidosis II Market
2.8 Key Manufacturers Mucopolysaccharidosis II Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Mucopolysaccharidosis II Status and Outlook by Region
3.1 Global Mucopolysaccharidosis II Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Mucopolysaccharidosis II Historic Market Size by Region
3.2.1 Global Mucopolysaccharidosis II Sales in Volume by Region (2018-2023)
3.2.2 Global Mucopolysaccharidosis II Sales in Value by Region (2018-2023)
3.2.3 Global Mucopolysaccharidosis II Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Mucopolysaccharidosis II Forecasted Market Size by Region
3.3.1 Global Mucopolysaccharidosis II Sales in Volume by Region (2024-2029)
3.3.2 Global Mucopolysaccharidosis II Sales in Value by Region (2024-2029)
3.3.3 Global Mucopolysaccharidosis II Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Mucopolysaccharidosis II by Application
4.1 Mucopolysaccharidosis II Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Research Center
4.1.4 Others
4.2 Global Mucopolysaccharidosis II Market Size by Application
4.2.1 Global Mucopolysaccharidosis II Market Size Overview by Application (2018-2029)
4.2.2 Global Mucopolysaccharidosis II Historic Market Size Review by Application (2018-2023)
4.2.3 Global Mucopolysaccharidosis II Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Mucopolysaccharidosis II Sales Breakdown by Application (2018-2023)
4.3.2 Europe Mucopolysaccharidosis II Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Mucopolysaccharidosis II Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Mucopolysaccharidosis II Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Mucopolysaccharidosis II Sales Breakdown by Application (2018-2023)
5 North America Mucopolysaccharidosis II by Country
5.1 North America Mucopolysaccharidosis II Historic Market Size by Country
5.1.1 North America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Mucopolysaccharidosis II Sales in Volume by Country (2018-2023)
5.1.3 North America Mucopolysaccharidosis II Sales in Value by Country (2018-2023)
5.2 North America Mucopolysaccharidosis II Forecasted Market Size by Country
5.2.1 North America Mucopolysaccharidosis II Sales in Volume by Country (2024-2029)
5.2.2 North America Mucopolysaccharidosis II Sales in Value by Country (2024-2029)
6 Europe Mucopolysaccharidosis II by Country
6.1 Europe Mucopolysaccharidosis II Historic Market Size by Country
6.1.1 Europe Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Mucopolysaccharidosis II Sales in Volume by Country (2018-2023)
6.1.3 Europe Mucopolysaccharidosis II Sales in Value by Country (2018-2023)
6.2 Europe Mucopolysaccharidosis II Forecasted Market Size by Country
6.2.1 Europe Mucopolysaccharidosis II Sales in Volume by Country (2024-2029)
6.2.2 Europe Mucopolysaccharidosis II Sales in Value by Country (2024-2029)
7 Asia-Pacific Mucopolysaccharidosis II by Region
7.1 Asia-Pacific Mucopolysaccharidosis II Historic Market Size by Region
7.1.1 Asia-Pacific Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Mucopolysaccharidosis II Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Mucopolysaccharidosis II Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Mucopolysaccharidosis II Forecasted Market Size by Region
7.2.1 Asia-Pacific Mucopolysaccharidosis II Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Mucopolysaccharidosis II Sales in Value by Region (2024-2029)
8 Latin America Mucopolysaccharidosis II by Country
8.1 Latin America Mucopolysaccharidosis II Historic Market Size by Country
8.1.1 Latin America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Mucopolysaccharidosis II Sales in Volume by Country (2018-2023)
8.1.3 Latin America Mucopolysaccharidosis II Sales in Value by Country (2018-2023)
8.2 Latin America Mucopolysaccharidosis II Forecasted Market Size by Country
8.2.1 Latin America Mucopolysaccharidosis II Sales in Volume by Country (2024-2029)
8.2.2 Latin America Mucopolysaccharidosis II Sales in Value by Country (2024-2029)
9 Middle East and Africa Mucopolysaccharidosis II by Country
9.1 Middle East and Africa Mucopolysaccharidosis II Historic Market Size by Country
9.1.1 Middle East and Africa Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Mucopolysaccharidosis II Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Mucopolysaccharidosis II Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Mucopolysaccharidosis II Forecasted Market Size by Country
9.2.1 Middle East and Africa Mucopolysaccharidosis II Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Mucopolysaccharidosis II Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Alexion Pharmaceuticals, Inc.
10.1.1 Alexion Pharmaceuticals, Inc. Company Information
10.1.2 Alexion Pharmaceuticals, Inc. Introduction and Business Overview
10.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Products Offered
10.1.5 Alexion Pharmaceuticals, Inc. Recent Development
10.2 AngioChem Inc.
10.2.1 AngioChem Inc. Company Information
10.2.2 AngioChem Inc. Introduction and Business Overview
10.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AngioChem Inc. Mucopolysaccharidosis II Products Offered
10.2.5 AngioChem Inc. Recent Development
10.3 ArmaGen Inc.
10.3.1 ArmaGen Inc. Company Information
10.3.2 ArmaGen Inc. Introduction and Business Overview
10.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.3.4 ArmaGen Inc. Mucopolysaccharidosis II Products Offered
10.3.5 ArmaGen Inc. Recent Development
10.4 Bioasis Technologies Inc.
10.4.1 Bioasis Technologies Inc. Company Information
10.4.2 Bioasis Technologies Inc. Introduction and Business Overview
10.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Products Offered
10.4.5 Bioasis Technologies Inc. Recent Development
10.5 Green Cross Corporation
10.5.1 Green Cross Corporation Company Information
10.5.2 Green Cross Corporation Introduction and Business Overview
10.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Green Cross Corporation Mucopolysaccharidosis II Products Offered
10.5.5 Green Cross Corporation Recent Development
10.6 Inventiva
10.6.1 Inventiva Company Information
10.6.2 Inventiva Introduction and Business Overview
10.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Inventiva Mucopolysaccharidosis II Products Offered
10.6.5 Inventiva Recent Development
10.7 JCR Pharmaceuticals Co., Ltd.
10.7.1 JCR Pharmaceuticals Co., Ltd. Company Information
10.7.2 JCR Pharmaceuticals Co., Ltd. Introduction and Business Overview
10.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.7.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Products Offered
10.7.5 JCR Pharmaceuticals Co., Ltd. Recent Development
10.8 Laboratorios Del Dr. Esteve S.A.
10.8.1 Laboratorios Del Dr. Esteve S.A. Company Information
10.8.2 Laboratorios Del Dr. Esteve S.A. Introduction and Business Overview
10.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Products Offered
10.8.5 Laboratorios Del Dr. Esteve S.A. Recent Development
10.9 RegenxBio Inc.
10.9.1 RegenxBio Inc. Company Information
10.9.2 RegenxBio Inc. Introduction and Business Overview
10.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.9.4 RegenxBio Inc. Mucopolysaccharidosis II Products Offered
10.9.5 RegenxBio Inc. Recent Development
10.10 Sangamo BioSciences, Inc.
10.10.1 Sangamo BioSciences, Inc. Company Information
10.10.2 Sangamo BioSciences, Inc. Introduction and Business Overview
10.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Products Offered
10.10.5 Sangamo BioSciences, Inc. Recent Development
10.11 Takeda
10.11.1 Takeda Company Information
10.11.2 Takeda Introduction and Business Overview
10.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Takeda Mucopolysaccharidosis II Products Offered
10.11.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Mucopolysaccharidosis II Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Mucopolysaccharidosis II Industrial Chain Analysis
11.4 Mucopolysaccharidosis II Market Dynamics
11.4.1 Mucopolysaccharidosis II Industry Trends
11.4.2 Mucopolysaccharidosis II Market Drivers
11.4.3 Mucopolysaccharidosis II Market Challenges
11.4.4 Mucopolysaccharidosis II Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Mucopolysaccharidosis II Distributors
12.3 Mucopolysaccharidosis II Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
